Good Collaborates on White Paper for FDA Drug Labeling Changes

July 23, 2019

CP3 affiliated faculty Dr. Chester "Bernie" Good contributed to a Duke-Margolis white paper outlining recommendations and a research agenda to guide the FDA after changes to drug safety labeling. The paper aims to minimize unintended consequences, and suggestions include involving an expert consortium to evaluate labeling changes and improving accessibility of the labeling changes website.